**Core Concept:** Substance abuse potential is associated with medications that can produce a subjective feeling of well-being or pleasure upon initiation, leading to continued use despite potential adverse effects.

**Why the Correct Answer is Right:** Benzodiazepines are a class of drugs that act on the central nervous system (CNS) by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) which leads to a calming effect and sedation. In some individuals, this effect can be pleasurable, leading to continued use despite potential risks and dependency.

**Why Each Wrong Option is Incorrect:**

A. Opioids (e.g., morphine, codeine) typically produce aversive side effects like nausea, drowsiness, and respiratory depression, reducing their potential for abuse.
B. Antidepressants like selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors (SNRIs) primarily target neurotransmitters like serotonin and norepinephrine, not producing a pleasurable feeling upon initiation.
C. Anxiolytics like benzodiazepines enhance GABAergic neurotransmission, leading to a calming effect and reduced anxiety but can potentially produce pleasurable effects in some individuals, making them a close contender but less strong than benzodiazepines.
D. Antipsychotics primarily target dopaminergic neurotransmission, which is not associated with a pleasurable feeling upon initiation, reducing their substance abuse potential.

**Clinical Pearl:** Assessing for potential substance abuse potential should be part of a thorough medication history, particularly when prescribing medications with CNS depressant effects like benzodiazepines and anxiolytics. Regularly reviewing the patient's medication regimen and monitoring for abuse or dependency symptoms is essential.